NAPROXEN

Product NDC
70518-2428
11-digit product format
705182428
Labeler code
70518
Product ID
70518-2428_c935bb3c-d8af-8ef2-e053-2995a90a661d
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
NAPROXEN
Dosage form
TABLET
Route
ORAL
Labeler
REMEDYREPACK INC.
Application
ANDA091416
Marketing category
ANDA
Marketing start
2019-11-18
Marketing end
0000-00-00
Substance
NAPROXEN
Active strength
500 mg/1
Pharmacologic classes
Cyclooxygenase Inhibitors [MoA],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC]
NDC exclude flag
No
Listing certified through
2022-12-31
Current FDA listing
Historical FDA.report record

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
70518-2428-02023-03-09C16284748780-1f386c64a-3230-0266-e053-dadaa90a7c1ad0349e19-6ac0-4aa5-8108-89a2516e9100
70518-2428-02023-01-30C16284748780-1f386c64a-3230-0266-e053-dadaa90a7c1ad0349e19-6ac0-4aa5-8108-89a2516e9100

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
70518-2428-07051824280030 TABLET in 1 BLISTER PACK (70518-2428-0) 30 tablet2019-11-180000-00-00NoNoCurrent